BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9865719)

  • 21. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
    Unoki M; Nakamura Y
    Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
    Cantley LC; Neel BG
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
    Furnari FB; Huang HJ; Cavenee WK
    Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y; Uegaki K; Kigawa J; Terakawa N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
    Matsushima-Nishiu M; Unoki M; Ono K; Tsunoda T; Minaguchi T; Kuramoto H; Nishida M; Satoh T; Tanaka T; Nakamura Y
    Cancer Res; 2001 May; 61(9):3741-9. PubMed ID: 11325847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells.
    Xu Z; Stokoe D; Kane LP; Weiss A
    Cell Growth Differ; 2002 Jul; 13(7):285-96. PubMed ID: 12133897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
    Vazquez F; Sellers WR
    Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways.
    Weng L; Brown J; Eng C
    Hum Mol Genet; 2001 Feb; 10(3):237-42. PubMed ID: 11159942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A surprising function for the PTEN tumor suppressor.
    Hopkin K
    Science; 1998 Nov; 282(5391):1027,1029-30. PubMed ID: 9841444
    [No Abstract]   [Full Text] [Related]  

  • 32. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
    Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
    Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
    Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
    J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.
    Sun H; Lesche R; Li DM; Liliental J; Zhang H; Gao J; Gavrilova N; Mueller B; Liu X; Wu H
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6199-204. PubMed ID: 10339565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice.
    Butler M; McKay RA; Popoff IJ; Gaarde WA; Witchell D; Murray SF; Dean NM; Bhanot S; Monia BP
    Diabetes; 2002 Apr; 51(4):1028-34. PubMed ID: 11916922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PTEN: a tumor suppressor with original properties].
    Roux P
    Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas.
    Zhang P; Steinberg BM
    Cancer Res; 2000 Mar; 60(5):1457-62. PubMed ID: 10728713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
    Fujii GH; Morimoto AM; Berson AE; Bolen JB
    Oncogene; 1999 Mar; 18(9):1765-9. PubMed ID: 10208437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways.
    Gao X; Neufeld TP; Pan D
    Dev Biol; 2000 May; 221(2):404-18. PubMed ID: 10790335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
    Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R
    Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.